Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

The RON receptor tyrosine kinase promotes metastasis by triggering epigenetic reprogramming through the thymine glycosylase MBD4 (gene expression array)


ABSTRACT: Metastasis is the major cause of death in cancer patients, yet the genetic/epigenetic programs that drive metastasis are poorly understood. Here, we report a novel epigenetic reprogramming pathway that is required for breast cancer metastasis. Concerted differential DNA methylation is initiated by activation of the RON receptor tyrosine kinase by its ligand, macrophage stimulating protein (MSP). Through PI3K signaling, RON/MSP promotes expression of the G:T mismatch-specific thymine glycosylase MBD4. RON/MSP and MBD4-dependent aberrant DNA methylation results in misregulation of a specific set of genes. Knockdown of MBD4 reverses methylation at these specific loci, and blocks metastasis. We also show that the MBD4 glycosylase catalytic residue is required for RON/MSP-driven metastasis. Analysis of human breast cancers revealed that this epigenetic program is significantly associated with poor clinical outcome. Furthermore, inhibition of Ron kinase activity with a new pharmacological agent blocks metastasis of patient-derived breast tumor grafts in vivo. To determine the molecular mechanisms by which RON/MSP drives breast cancer metastasis, we performed microarray gene expression profiling of MCF7, MCF7-RON/MSP and MCF7-RON/MSP-shMBD4 cells.

ORGANISM(S): Homo sapiens

SUBMITTER: Stephanie Cunha 

PROVIDER: E-GEOD-52567 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

The RON receptor tyrosine kinase promotes metastasis by triggering MBD4-dependent DNA methylation reprogramming.

Cunha Stéphanie S   Lin Yi-Chun YC   Goossen Elizabeth A EA   DeVette Christa I CI   Albertella Mark R MR   Thomson Stuart S   Mulvihill Mark J MJ   Welm Alana L AL  

Cell reports 20140102 1


Metastasis is the major cause of death in cancer patients, yet the genetic and epigenetic programs that drive metastasis are poorly understood. Here, we report an epigenetic reprogramming pathway that is required for breast cancer metastasis. Concerted differential DNA methylation is initiated by the activation of the RON receptor tyrosine kinase by its ligand, macrophage stimulating protein (MSP). Through PI3K signaling, RON/MSP promotes expression of the G:T mismatch-specific thymine glycosyla  ...[more]

Similar Datasets

2014-01-02 | E-GEOD-52687 | biostudies-arrayexpress
2014-01-02 | GSE52688 | GEO
2014-01-02 | GSE52687 | GEO
2014-01-02 | GSE52567 | GEO
| PRJNA229804 | ENA
| PRJNA229803 | ENA
| PRJNA229805 | ENA
2022-02-02 | GSE155011 | GEO
2019-06-14 | GSE129075 | GEO
| PRJNA229394 | ENA